Thomas Olson
Directeur des opérations chez Acesis BioMed US, Inc.
Profil
Mr. Thomas B.
Olson is a Chief Operating Officer & Secretary at Acesis Holdings Corp., a Chief Operating Officer at Acesis BioMed US, Inc. and a Member at Cresthill Associates, LLC.
Postes actifs de Thomas Olson
| Sociétés | Poste | Début |
|---|---|---|
Acesis BioMed US, Inc.
 Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Directeur des opérations | - |
Acesis Holdings Corp.
 Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Directeur des opérations | 03/10/2022 |
| Cresthill Associates, LLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Cresthill Associates, LLC | |
Acesis BioMed US, Inc.
Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Health Technology |
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Health Technology |
